Roche
Search results
Lonza Singapore is a mammalian cell culture and cell and gene therapy CDMO of biopharmaceutical products, including monoclonal antibodies (mAbs), cellular therapeutics and other recombinant proteins.
1 day ago · Find your job opportunity at Lonza and become part of our global teams. Submit your application now and get one step closer to making a meaningful...
Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market.
Jan 10, 2024 · Lonza Biologics Tuas Pte Ltd. https://www.lonza.com/about-us/our-locations/tuas-singapore. Lonza is a preferred global partner to the pharmaceutical, biotech, and nutrition markets, focusing on enabling treatments that prevent illness and support healthier lifestyles.
Oct 7, 2021 · Lonza's expansion in Singapore will establish additional capacity for cell culture, purification, and analytical services for biologics.
Discover Lonza Bioscience's innovative solutions for life science research and biomanufacturing in Singapore and beyond.
Dec 6, 2006 · Lonza and Bio*One Capital will build a large-scale mammalian cell culture facility in Singapore to manufacture commercial biopharmaceuticals, under a new joint venture, Lonza Biologics Tuas.
Oct 11, 2021 · Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics.
Lonza | 319,742 followers on LinkedIn. A Meaningful Difference for 125 Years | At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization.
Genentech exercised its option to buy Lonza’s new 80,000-litre large-scale mammalian biologics manufacturing facility in Singapore for $290 million up front and potentially another $70 million...
